Related Experiment Video

Updated: Aug 23, 2026

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

Mouse Huntington's disease homolog mRNA levels: variation and allele effects

Karen T Dixon1, Jamie A Cearley, Jesse M Hunter

  • 1Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Gene Expression
|June 18, 2004
PubMed

Insights

Nongenetic factors significantly influence Huntington's disease homolog (Hdh) mRNA levels. This finding suggests that therapies targeting mutant huntingtin mRNA may be viable for Huntington's disease treatment.

Area of Science:

  • Molecular Biology
  • Genetics
  • Neuroscience

Background:

  • Huntington's disease (HD) is a neurodegenerative disorder caused by expanded CAG repeats in the huntingtin gene.
  • Understanding the regulation of huntingtin homolog (Hdh) mRNA levels is crucial for developing effective HD therapies.

Purpose of the Study:

  • To investigate the factors influencing Hdh mRNA expression in mice.
  • To assess the impact of Hdh gene dosage on mRNA levels.
  • To explore the relationship between Hdh expression and chromatin accessibility.

Main Methods:

  • Measurement of Hdh mRNA levels in mice with varying Hdh alleles.
  • Analysis of Hdh mRNA in genetically identical wild-type mice.
  • Assessment of Hdh mRNA levels in mice heterozygous for Hdh promoter deletion.
  • Evaluation of Cre-mediated deletion susceptibility at the Hdh locus.

Main Results:

  • Significant variation in Hdh mRNA levels was observed even in genetically identical mice, indicating nongenetic influences.
  • Striatal Hdh mRNA levels were reduced in a mouse model with expanded CAG repeats (Hdh(CAG)150).
  • Loss of one Hdh allele reduced mRNA levels, suggesting limited compensatory mechanisms.
  • Hdh locus susceptibility to Cre-mediated deletion correlated with high Hdh mRNA levels in brain and testes.

Conclusions:

  • Hdh mRNA expression is influenced by nongenetic factors and gene dosage.
  • The absence of strong compensatory mechanisms supports therapeutic strategies aimed at degrading mutant huntingtin mRNA.
  • Chromatin accessibility in brain and testes may be linked to high Hdh expression levels in these tissues.

More Related Videos

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations10:17

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

Published on: November 3, 2010

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Genetic Lingo01:11

Genetic Lingo

Overview
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...